2010 Idaho Code
TITLE 39 HEALTH AND SAFETY
CHAPTER 3 ALCOHOLISM AND INTOXICATION TREATMENT ACT
39-303 INTERAGENCY COMMITTEE ON SUBSTANCE ABUSE PREVENTION AND TREATMENT.

TITLE 39

HEALTH AND SAFETY

CHAPTER 3

ALCOHOLISM AND INTOXICATION TREATMENT ACT

39-303. Interagency committee on substance abuse prevention and treatment. [EFFECTIVE UNTIL JULY 1, 2011] (1) There is hereby created within the office of drug policy, as provided for in section 67-821, Idaho Code, the interagency committee on substance abuse prevention and treatment. The purpose of the interagency committee is to focus on statewide efforts to address substance abuse by assessing statewide needs, developing a statewide plan, and coordinating and directing efforts of all state entities that use public funds for efforts to address substance abuse.

(2) Membership of the interagency committee shall be:

(a) The administrator of the office of drug policy, or the administrator’s designee;

(b) The director of the department of health and welfare, or the director’s designee;

(c) The director of the department of correction, or the director’s designee;

(d) The director of the department of juvenile corrections, or the director’s designee;

(e) The superintendent of public instruction, or the superintendent’s designee;

(f) The director of the Idaho state police, or the director’s designee;

(g) The director of the Idaho transportation department, or the director’s designee;

(h) The administrative director of the supreme court, or the director’s designee;

(i) The chairperson of the state board of health and welfare, or the chair’s designee;

(j) The chairperson of the board of correction, or the chair’s designee;

(k) The chairperson of the board of juvenile corrections, or the chair’s designee;

(l) The chairperson of the drug court and mental health court coordinating committee established under section 19-5606, Idaho Code, or the chair’s designee;

(m) The chairperson of the senate health and welfare committee, or the chair’s designee;

(n) The chairperson of the house of representatives health and welfare committee, or the chair’s designee;

(o) The chairperson of the senate judiciary and rules committee, or the chair’s designee;

(p) The chairperson of the house of representatives judiciary, rules and administration committee, or the chair’s designee;

(q) The chief administrative official of each other state governmental entity that expends funds to provide services to address substance abuse, or that chief administrative official’s designee;

(r) One (1) representative of the regional advisory committees as determined in section 39-303A, Idaho Code; and

(s) Such additional ad hoc nonvoting members as the administrator of the office of drug policy may designate.

Interagency committee members shall serve without additional compensation but may be reimbursed by their respective entities for interagency committee related travel and expenses pursuant to chapter 20, title 67, Idaho Code.

(3) The duties of the interagency committee shall be to:

(a) Develop and annually update a statewide plan to address substance abuse, including the creation of common performance measures;

(b) Exchange information on programs that address substance abuse;

(c) Identify and promote opportunities for coordination, cooperation, collaboration and elimination of service duplication among relevant state entities;

(d) Monitor programs and evaluate outcomes;

(e) Identify state needs for addressing substance abuse, including promoting implementation of multiagency strategic budgeting;

(f) Review and assess the use of funds available to address substance abuse;

(g) Promote coordinated approaches to substance abuse prevention and treatment;

(h) Research, share, discuss and promote the use of best practices;

(i) Annually report to the legislature and governor prior to the beginning of the legislative session on the state’s efforts to address substance abuse, including descriptions of:

(i) The statewide need for services to address substance abuse;

(ii) The state’s capacity to meet those identified needs;

(iii) The types of substance abuse services being provided, and the groups and numbers of people served;

(iv) Which programs are effective in addressing substance abuse and which are not; and

(v) An overall evaluation of the state’s efforts to address substance abuse; and

(j) Develop and submit through the office of drug policy, no later than the first of September, any budgeted program enhancements or program expansions in a coordinated budget request pursuant to section 67-3502, Idaho Code, including estimated appropriation needs for the next fiscal year by the judicial department, the department of correction, the department of health and welfare, the department of juvenile corrections and any other department or agency, for expenditures relating to services provided by such department or agency in connection with the statewide substance abuse prevention and treatment delivery system.

(4) Each state administrative agency that expends public funds to provide services to address substance abuse shall report semiannually to the interagency committee, and shall include the following information:

(a) The amount of moneys expended on programs or services to address substance abuse;

(b) The number of individuals served or the extent of services provided, by specific type of service;

(c) The number of individuals not served and/or placed on waiting lists for services, by specific type of service;

(d) The agency’s overall capacity to provide specific types of services;

(e) The completion, dropout and relapse rates for treatment programs, and the relevant indicators for other services and programs;

(f) The average length of stay for individuals in each type of treatment program, or the average duration of other services and programs.

The interagency committee shall establish procedures for collecting and compiling the information required for these reports and the distribution of the compiled information to all interagency committee members, the legislature and the governor.

(5) The administrator of the office of drug policy shall serve as chairperson of the interagency committee. The interagency committee shall meet at least once each calendar quarter, or more frequently at the call of the chairperson. Public notice of each interagency committee meeting shall be given two (2) weeks in advance thereof. Any interagency committee member may submit agenda items to be discussed at the interagency committee meetings.

(6) Each state administrative agency or entity with representation on the interagency committee shall share in providing the administrative support required by the interagency committee. The allocation of administrative support among the state administrative agencies represented on the interagency committee shall be collectively determined by the chief administrative officer of each such agency and reassessed at least annually.